(Albany, US) DelveInsight has launched a new report Hypertriglyceridemia Epidemiology
DelveInsight’s Hypertriglyceridemia Epidemiology Forecast to 2030 report delivers an in-depth understanding of the disease, historical and forecasted Hypertriglyceridemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Hypertriglyceridemia refers to a fasting plasma triglyceride measurement that is increased, typically above the 95th percentile for age and sex along with additional quantitative or qualitative lipoprotein abnormalities. Patients can fluctuate between hypertriglyceridemia states: given appropriate metabolic stress, mild or moderate hypertriglyceridemia can deteriorate into severe hypertriglyceridemia. The two main sources of plasma triglycerides (also known as triacylglycerol) are exogenous (i.e., from dietary fat)—carried in chylomicrons, and endogenous (from the liver)—carried in very-low-density lipoprotein (VLDL) particles.
Request for free sample page:- https://www.delveinsight.com/sample-request/hypertriglyceridemia-epidemiology-forecast
Hypertriglyceridemia Epidemiology Perspective by DelveInsight
The Hypertriglyceridemia epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Hypertriglyceridemia epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Hypertriglyceridemia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Hypertriglyceridemia Epidemiology
HTG can be divided into primary and secondary types. In primary HTG, chylomicrons normally are cleared rapidly from plasma by lipoprotein lipase with apolipoprotein (apo) C-II as a cofactor—familial chylomicronemia (hyperlipoproteinemia type 1, in the Fredrickson system) and primary mixed hyperlipidemia (type 5) are each characterized by the pathologic presence of chylomicrons after a 12–14 h period of fasting—whereas, in secondary HTG, obesity is probably the metabolic stressor most frequently associated with hypertriglyceridemia, although associations with poorly controlled type 2 diabetes and excessive alcohol consumption are also common (associated with a secondary cause/acquired).
Key facts of the report
Hypertriglyceridemia Report Scope
Table of content
1. Key Insights
2. Executive Summary of Hypertriglyceridemia
3. Hypertriglyceridemia: Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Why should you buy this report?
Related Reports
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/